A new trading day began on Tuesday, with Oncology Institute Inc (NASDAQ: TOI) stock price down -9.15% from the previous day of trading, before settling in for the closing price of $3.06. TOI’s price has ranged from $0.13 to $3.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 16.48% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 46.48%. With a float of $38.24 million, this company’s outstanding shares have now reached $88.93 million.
In an organization with 825 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 10.42%, operating margin of -12.91%, and the pretax margin is -15.96%.
Oncology Institute Inc (TOI) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of Oncology Institute Inc is 57.13%, while institutional ownership is 15.22%. The most recent insider transaction that took place on May 20 ’25, was worth 622,808. Before that another transaction happened on May 20 ’25, when Company’s 10% Owner proposed sale 1,796,468 for $3.06, making the entire transaction worth $5,497,192.
Oncology Institute Inc (TOI) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 58.70% during the next five years compared to -488.57% drop over the previous five years of trading.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Here are Oncology Institute Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Oncology Institute Inc (TOI)
Let’s dig in a bit further. During the last 5-days, its volume was 3.09 million. That was better than the volume of 1.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.24%. Additionally, its Average True Range was 0.39.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 78.16%, which indicates a significant increase from 50.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 146.27% in the past 14 days, which was higher than the 143.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.93, while its 200-day Moving Average is $0.80. However, in the short run, Oncology Institute Inc’s stock first resistance to watch stands at $3.02. Second resistance stands at $3.27. The third major resistance level sits at $3.40. If the price goes on to break the first support level at $2.65, it is likely to go to the next support level at $2.52. Assuming the price breaks the second support level, the third support level stands at $2.27.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
With a market capitalization of 247.96 million, the company has a total of 75,559K Shares Outstanding. Currently, annual sales are 393,410 K while annual income is -64,660 K. The company’s previous quarter sales were 104,410 K while its latest quarter income was -19,590 K.
